Kern Pharma mulls new acquisitions
Catalan Economy
26 Jun 2009
Kern pharma, a unit of pharmaceutical group indukern, has announced that it is looking into new acquisitions to grow in catalonia and strengthen its presence in international markets. indukern ceo raul diaz-varela confirmed that its company is interested in acquiring the solvay pharma plant in parets del vallès or one of labiana factories. kern facilities in terrassa could reach its maximum production capacity in less than two years, he added. the group is also studying acquisitions in france and italy to strengthen its european business. in 2008, indukern posted revenue of 550 million euros, up 7.8% over the previous year.
source: expansión catalunya 25/06/09
Related News and Success stories.
-
19 Dec 2024
Catalonia's Tech Hubs: Cultivating Talent and Driving Innovation in Europe
-
18 Dec 2024
Catalonia: A Global Example of Cluster Excellence
-
13 Dec 2024
YPlasma, best 2024 startup of Catalonia
-
11 Dec 2024
Barcelona will host one of the seven AI Innovation factories in Europe